KRYXANA 200MG TABLET

Form: Tablets

Pack Size: 21 TABLETS

Marketed by: NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV)

MRP: ₹24435.00

NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV): Kryxana 200MG Tablet, 21 tablets, salt ribociclib 200mg. Its MRP stays at Rs 24,435 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 18,617.14. Group: CDK4/6 inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: avoid grapefruit; check co-prescriptions that prolong QT. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.